XML 15 R3.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Investments:    
Fixed maturities available-for-sale, at fair value (amortized cost of $68,636 and $68,136) (allowance for credit losses of $22 and $13) $ 73,076 $ 76,353
Mortgage loans on real estate (net of allowance for credit losses of $62 and $81) 14,016 13,142
Policy loans 3,540 3,635
Other equity investments [1] 2,759 1,342
Trading securities, at fair value 379 5,340
Other invested assets 2,910 2,383
Total investments 96,680 102,195
Cash and cash equivalents 1,815 2,043
Deferred policy acquisition costs 4,267 3,816
Amounts due from reinsurers (allowance for credit losses of $5 and $5 ) (includes amounts accounted for at fair value of $5,813and $—) [2] 13,300 3,053
Loans to affiliates 1,900 900
GMIB reinsurance contract asset, at fair value 2,068 2,859
Current and deferred income taxes 842 0
Other assets 3,023 3,078
Separate Accounts assets 143,912 133,350
Total Assets 267,807 251,294
LIABILITIES    
Policyholders’ account balances 75,467 63,109
Future policy benefits and other policyholders' liabilities 36,851 40,151
Broker-dealer related payables 630 1,064
Amounts due to reinsurers 135 122
Current and deferred income taxes 0 234
Other liabilities 2,078 1,580
Separate Accounts liabilities 143,912 133,350
Total Liabilities 259,073 239,610
Redeemable noncontrolling interest [3] 28 41
Commitments and contingent liabilities (Note 16)
Equity attributable to Equitable Financial:    
Common stock, $1.25 par value; 2,000,000 shares authorized, issued and outstanding 2 2
Additional paid-in capital 8,546 7,841
Retained earnings (2,199) (795)
Accumulated other comprehensive income (loss) 2,357 4,595
Total Equity 8,706 11,643
Total Liabilities, Redeemable Noncontrolling Interest and Equity $ 267,807 $ 251,294
[1] See Note 2 of the Notes to these Consolidated Financial Statements for details of balances with VIEs.
[2] Represents the fair value of the ceded reserves to Venerable. See Note 1 of the Notes to these Consolidated Financial Statements for details of the Venerable transaction and Note 7 of the Notes to these Consolidated Financial Statements.
[3] See Note 18 of the Notes to these Consolidated Financial Statements for details of redeemable noncontrolling interest.